CGB1003

N/A

Report date: 2025/09/04 17:16:57

NME

Base Information

Drug NameCGB1003

Drug Alias NameCGB-1003

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate > Antibody-Oligonucleotide conjugate > Antibody-siRNA conjugate

Mechanisms of ActionTransferrin receptor protein 1 modulators

TargetsTransferrin receptor protein 1

Therapy Area/IndicationsObesity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesJiajin Biomedicine (Shanghai) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesJiajin Biomedicine (Shanghai) Co Ltd

Inactive CompaniesN/A

Active IndicationsObesity

Inactive IndicationsN/A

Other Information

ATC CodeN/A